LoQus23 is an England-based biotechnology company that develops and markets small molecule therapies for the treatment of Huntington’s and other triplet repeat diseases.
Business Model:
Revenue: $1M
Employees: 2-10
Address: Babraham Research Campus
City: Cambridge
State: england
Zip: CB22 3AT
Country: GB
LoQus23 is an England-based biotechnology company that develops and markets small molecule therapies for the treatment of Huntington’s and other triplet repeat diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2021 | Seed Round | $0 |
Dementia Discovery Fund Novartis Venture Fund Dementia Discovery Fund Novartis Venture Fund |
1/2019 | Seed Round | 1 | $5.7M |
Dementia Discovery Fund Dementia Discovery Fund |
1/2018 | Seed Round | 1 | - |
SV Health Investors SV Health Investors |
11/2021 | Seed | $9.4M |
Novartis Venture Fund SV Health Investors |
11/2019 | Seed | $6M | 11/2021 | Seed Round | 2 | $9.4M |
Dementia Discovery Fund Novartis Venture Fund Dementia Discovery Fund Novartis Venture Fund |
1/2018 | Seed Round | 1 | - |
SV Health Investors SV Health Investors |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|